PFCD Applauds Senate Action on PBMs
- jenniferb35
- Dec 5, 2025
- 2 min read
December 5, 2025 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the introduction of the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act:
“The Partnership to Fight Chronic Disease (PFCD) applauds Senate Finance Committee Chairman Mike Crapo and Ranking Member Ron Wyden for introducing the bipartisan Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act, which aims to fix market distortions and lower prescription drug costs for patients and taxpayers. For the more than 190 million Americans living with one or more chronic conditions, reforms that increase transparency, fairness, and accountability among PBMs are essential to improving access and affordability.
“Efforts to make America healthier require policymakers to address misaligned incentives that allow PBMs to profit while patients face rising premiums, deductibles, and coinsurance at the pharmacy counter. By delinking PBM compensation from list prices and requiring that Medicaid payments flow more directly to pharmacies and dispensing providers, this legislation moves the system closer to one that prioritizes patients over middlemen.
“This legislation’s provisions to strengthen reporting, audit authority, and ‘any willing pharmacy’ contracting will help safeguard independent and rural pharmacies that many people with chronic conditions rely on for timely access to medicines and counseling. These steps, combined with greater oversight of PBM practices across Medicare and Medicaid, reflect the kind of bipartisan, patient-centered solutions PFCD has consistently championed to protect access while addressing affordability.
“Achieving better health outcomes requires a comprehensive approach that pairs prevention with reliable access to evidence-based treatments. Greater transparency when it comes to cost and access for prescribed treatments is essential for people living with chronic conditions and the providers supporting their care. This bill is an important step in that direction, and PFCD urges Congress to swiftly advance this legislation.”

